文献速递慢性静脉疾病

MCP1 基因 rs1024611 功能多态性与下肢静脉曲张风险相关

Functional polymorphism rs1024611 in the MCP1 gene is associated with the risk of varicose veins of lower extremities.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2017-02-20

该病例对照研究纳入 470 例原发性下肢静脉曲张(PVVs)患者与 269 名无慢性静脉疾病史对照,均为俄罗斯族,采用实时 PCR 等位基因分型及 logistic 回归分析。结果显示 MCP1 rs1024611 G/G 基因型与 PVVs 风险升高相关(OR 1.87,95%CI 1.02-3.44,P=.04),亚组分析仅见于 C2 级、发病年龄<30 岁及无家族史患者。结论提示 MCP-1 及炎症可能参与 PVVs 发病。

要点

  • MCP1 rs1024611 G/G 基因型与原发性下肢静脉曲张风险升高相关(OR 1.87)。
  • 关联仅见于 C2 级、发病年龄<30 岁及无家族史亚组。
  • 结果提示炎症可能参与原发性下肢静脉曲张的发病机制。

核心结论

  • MCP1 rs1024611 多态性与原发性下肢静脉曲张风险相关,提示 MCP-1 及炎症可能参与其发病。

研究设计与样本

  • 病例对照研究,病例组 470 例原发性下肢静脉曲张患者,对照组 269 名无慢性静脉疾病史个体,均为俄罗斯族。
  • 基因型采用实时聚合酶链反应等位基因 discrimination 法测定,关联分析采用 logistic 回归。

主要发现

  • G/G 基因型与 PVVs 风险升高相关(OR 1.87,95%CI 1.02-3.44,P=.04)。
  • C2 级患者中亚组关联:等位基因 G OR 1.62(95%CI 1.13-2.33,P=.008),G/G 基因型 OR 3.22(95%CI 1.43-7.27,P=.005)。
  • 发病年龄<30 岁患者中亚组关联:等位基因 G OR 1.41(95%CI 1.08-1.85,P=.01),G/G 基因型 OR 2.35(95%CI 1.22-4.55,P=.01)。
  • 无家族史患者中亚组关联:等位基因 G OR 1.46(95%CI 1.02-2.09,P=.04),G/G 基因型 OR 2.50(95%CI 1.11-5.63,P=.03)。

临床怎么用

  • MCP1 rs1024611 基因型或可作为原发性下肢静脉曲张风险评估的候选遗传标记,尤其适用于 C2 级、早发及无家族史患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Monocyte chemoattractant protein 1 (MCP-1) is a chemokine responsible for monocyte, basophil, and T-lymphocyte attraction. Polymorphism rs1024611 located in the regulatory region of the MCP1 gene has previously been shown to be associated with increased MCP-1 production. In our study, we aimed to examine the association of rs1024611 with the risk of primary varicose veins (PVVs) of lower extremities. METHODS: The case group comprised 470 patients with PVVs, and the control group included 269 individuals without a history of chronic venous disease. All cases and controls were ethnic Russians. Genotypes were determined by real-time polymerase chain reaction allelic discrimination. Association was studied by logistic regression analysis. RESULTS: We revealed the association of genotype G/G with the increased risk of PVVs (odds ratio [OR], 1.87; 95% confidence interval [CI], 1.02-3.44; P = .04). In the subgroup analysis, association was revealed only in patients with C2 Clinical, Etiology, Anatomy, and Pathophysiology class (allele G: OR, 1.62 [95% CI, 1.13-2.33; P = .008]; genotype G/G: OR, 3.22 [95% CI, 1.43-7.27; P = .005]), in patients with age at onset of PVVs before 30 years (allele G: OR, 1.41 [95% CI, 1.08-1.85; P = .01]; genotype G/G: OR, 2.35 [95% CI, 1.22-4.55; P = .01]), and in patients who declared no family history (allele G: OR, 1.46 [95% CI, 1.02-2.09; P = .04]; genotype G/G: OR, 2.50 [95% CI, 1.11-5.63; P = .03]). CONCLUSIONS: Our results provide evidence for MCP-1 involvement in the development of PVVs and indicate that inflammation could be implicated in the pathogenesis of this condition.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Shadrina AS, Smetanina MA, Sevost'ianova KS, et al. Functional polymorphism rs1024611 in the MCP1 gene is associated with the risk of varicose veins of lower extremities. J Vasc Surg Venous Lymphat Disord. 2017. PMID: 28623996. doi:10.1016/j.jvsv.2016.12.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。